Tema ETFs’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$823K Sell
2,220
-1,343
-38% -$474K 0.03% 330
2026
Q2
$1.28M Buy
3,563
+290
+9% +$88.7K 0.04% 246
2026
Q1
$820K Buy
3,273
+14
+0.4% +$3.48K 0.06% 269
2025
Q4
$897K Sell
3,259
-8
-0.2% -$2.19K 0.07% 257
2025
Q3
$857K Buy
3,267
+1,290
+65% +$314K 0.07% 287
2025
Q2
$433K Sell
1,977
-292
-13% -$62.4K 0.11% 144
2025
Q1
$508K Sell
2,269
-911
-29% -$251K 0.15% 110
2024
Q4
$1.04M Buy
+3,180
New +$1M 0.43% 65

Other funds holding WST

Tema ETFs's WST Position: Q3 2026 in Review

Tema ETFs reduced its West Pharmaceutical (WST) stake by 38% in Q3 2026, selling an estimated $474K and leaving 2,220 shares worth $823K. The position accounts for 0.03% of the portfolio, ranked #330.

Tema ETFs first reported a position in WST in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.28M in Q2 2026. 141 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Tema ETFs held 2,220 shares of West Pharmaceutical worth $823K as of Q3 2026.
  • Tema ETFs sold 1,343 West Pharmaceutical shares in Q3 2026, an estimated $474K.
  • West Pharmaceutical made up 0.03% of Tema ETFs's portfolio in Q3 2026, its #330 holding.
  • Tema ETFs first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
  • Tema ETFs's West Pharmaceutical position peaked at $1.28M in Q2 2026.
  • 141 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.